Sig Brokerage »

Alnylam Pharmaceuticals shares owned by Sig Brokerage

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Sig Brokerage from 13F filings

Historical chart of Sig Brokerage investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Sig Brokerage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Sig Brokerage

Quarter filed Position value Share count Share price at filing
2025-12-31 $994k 2.5k 397.65

More positions owned by Sig Brokerage

Spdr Gold Tr Gold Shs Put Option (GLD)
Meta Platforms Cl A Put Option (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Apollo Global Mgmt (APO)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
Ishares Msci Brazil Etf (EWZ)
Palantir Technologies Cl A Put Option (PLTR)
Advanced Micro Devices (AMD)
salesforce Put Option (CRM)
Arm Holdings Sponsored Ads Put Option (ARM)
UnitedHealth (UNH)
Select Sector Spdr Tr State Street Hea (XLV)
Vaneck Etf Trust Gold Miners Etf (GDX)

View all positions for Sig Brokerage

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals